This large, prospective evaluation of haptoglobin (Hp) typing demonstrates how 40% of diabetic patients can achieve significant cardiovascular benefit from tight glycemic control. The results of a prospective
Mundinter’s agreement calls for minimum sales of 300k units the first year, 600k units the second, 1.0mm units the third, 1.1mm the fourth and minimum of 1.2mm units
This clinical trial is a 12-day, single-center, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of CRx-191 in reducing psoriatic infiltrate band thickness in subjects with plaque
Immunization with Sanofi Pasteur’s tetravalent dengue candidate vaccine generated a sero-neutralizing antibody response against all four serotypes of the virus responsible for dengue fever in 100% of adults
Transgenomic’s European sales and support organization will market, sell and service the instruments. BioView’s products include the Duet, Allegro and Accord automated workstations for the scanning and classification
Under the terms of the collaboration agreement and related stock purchase agreement, GTx and Merck will combine their respective selective androgen receptor modulators (SARM) research programs. GTx will
The Phase II/III early-stage and late-stage retinitis pigmentosa (RP) are randomized, multi-centered, double-masked, sham-controlled studies evaluating NT-501 in 60 subjects with early-stage and late-stage RP, respectively. Visual field
RPL554 is a long-acting bronchodilator or anti-inflammatory molecule being developed to treat hay fever (rhinitis), asthma and chronic obstructive pulmonary disease. The inhalation studies will be undertaken by
While the results of this exploratory study did not achieve its specified primary endpoint (control of serum phosphate to within normal levels), more Fosrenol treated patients achieved this
ATIR is under development to prevent life-threatening graft versus host disease (GvHD), a major complication of allogeneic bone marrow transplantations. By preventing the occurrence of GvHD, ATIR enables
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.